Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 39, 2010 - Issue 4
Submit an article Journal homepage
682
Views
37
CrossRef citations to date
0
Altmetric
Articles

Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey

V Brodszky Health Economics and Technology Assessment Research Centre, Corvinus University of BudapestCorrespondence[email protected]
,
M Péntek Rheumatology, Flor Ferenc County Hospital
,
PV Bálint National Institute of Rheumatology and Physiotherapy
,
P Géher Polyclinic of the Hospitaller Brothers of St John of God in Budapest
,
O Hajdu Department of Statistics, Corvinus University of Budapest
,
L Hodinka National Institute of Rheumatology and Physiotherapy
,
G Horváth Department of Immunology and Rheumatology, University of Pécs
,
É Koó Polyclinic of the Hospitaller Brothers of St John of God in Budapest
,
A Polgár National Institute of Rheumatology and Physiotherapy
,
M Seszták National Institute of Rheumatology and Physiotherapy
,
S Szántó Division of Rheumatology, Third Department of Medicine, University of Debrecen
,
I Ujfalussy Department of Rheumatology, State Health Centre, Budapest, Hungary
&
L Gulácsi Health Economics and Technology Assessment Research Centre, Corvinus University of Budapest
 show all
Pages 303-309 | Accepted 06 Nov 2009, Published online: 18 Feb 2010

References

  • Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl 2):ii14–17.
  • Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, An overview of economic evaluations for drugs used in rheumatoid arthritis: focus on tumour necrosis factor-alpha antagonists. Drugs 2005;65:473–96.
  • McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162–9.
  • Healy PJ, Helliwell PS. Psoriatic arthritis quality of life instrument: an assessment of sensitivity and response to change. J Rheumatol 2008;35:1359–61.
  • Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O’Connor P, Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis 2007;66:778–81.
  • Bravo Vergel Y, Hawkins NS, Claxton K, Asseburg C, Palmer S, Woolacott N, The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford) 2007;46:1729–35.
  • Tammaru M, Lember M, Polluste K, McKenna SP. Cultural adaptation of quality of life measures. Scand J Rheumatol 2007;36:406–7.
  • Lovas K, Koo E, Whalley D, Meads D, Kalo Z, McKenna SP. [The validation of a disease specific quality of life instrument in patients with psoriatic arthritis], in Hungarian. LAM 2002;12:389–95.
  • Szende A, Nemeth R. [Health-related quality of life of the Hungarian population], in Hungarian. Orv Hetil 2003;144:1667–74.
  • Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005;64(Suppl 2):ii49–54.
  • Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978;157:238–44.
  • Kind P, Brooks R, Rabin R, eds. EQ-5D Concepts and Methods: A Developmental History. Dordrecht, The Netherlands: Springer; 2005.
  • Gulfe A, Kristensen LE, Saxne T, Jacobsson LT, Petersson IF, Geborek P. Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden. Ann Rheum Dis 2009 (doi:10.1136/ard.2008.103473).
  • Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873–84.
  • Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167–78.
  • Helland Y, Dagfinrud H, Kvien TK. Perceived influence of health status on sexual activity in RA patients: associations with demographic and disease-related variables. Scand J Rheumatol 2008;37:194–9.
  • Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation. Scand J Rheumatol 2009:38:246–50.
  • Wallenius M, Skomsvoll JF, Koldingsnes W, Rodevand E, Mikkelsen K, Kaufmann C, Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scand J Rheumatol 2009;38:178–83.
  • Husted JA, Tom BD, Farewell VT, Schentag CT, Gladman DD. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 2007;56:840–9.
  • Cohen J. Statistical power for the behavioral sciences, 2nd edn. Hillsdale, NJ: Erlbaum Associates, 1988.
  • Cohen J. A power primer. Psychol Bull 1992;112:155–9.
  • Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528–37.
  • Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Sci Med 2005;60:1571–82.
  • Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ 2009. doi:10.1002/hec.1505.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.